Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2014

01.06.2014 | Review

From Ischochymia to Gastroparesis: Proposed Mechanisms and Preferred Management of Dyspepsia Over the Centuries

verfasst von: Klaus Bielefeldt

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Dyspeptic symptoms are common with most patients suffering functional disorders that remain a therapeutic challenge for medical practitioners. Within the last three decades, gastric infection, altered motility, and hypersensitivity have gained and lost traction in explaining the development of functional dyspepsia. Considering these shifts, the aim of this review was to analyze changing understanding of and approaches to dyspepsia over a longer time period. Monographs, textbooks, and articles published during the last three centuries show that our understanding of normal gastric function has improved dramatically. With increased insight came new ideas about disease mechanisms, diagnostic options, and treatments. Despite shifts over time, the importance of functional abnormalities was recognized early on and explained in the context of societal influences and stressors, anxieties, and biological influences, thus resembling the contemporary biopsychosocial model of illness. Symptoms were often attributed to changes in secretion, motility, and sensation or perception with technological innovation often influencing proposed mechanisms and treatments. Many of the principles or even agents applied more than a century ago are still part of today’s approach. This includes acid suppression, antiemetics, analgesics, and even non-pharmacologic therapies, such as gastric decompression or electrical stimulation of the stomach. This historical information does not only help us understand how we arrived at our current state of knowledge and standards of care, it also demonstrates that enthusiastic adoption of various competing explanatory models and the resulting treatments often did not survive the test of time. In view of the benign prognosis of dyspepsia, the data may function as a call for caution to avoid the potential harm of overly aggressive approaches or treatments with a high likelihood of adverse effects.
Literatur
1.
Zurück zum Zitat Agreus L. The epidemiology of functional gastrointestinal disorders. Eur J Sur Suppl. 1998;583:60–66. Agreus L. The epidemiology of functional gastrointestinal disorders. Eur J Sur Suppl. 1998;583:60–66.
2.
Zurück zum Zitat Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580.PubMed Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580.PubMed
3.
Zurück zum Zitat Wildner-Christensen M, Moller Hansen J, Schaffalitzky De Schaffalitzky O. Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population. Gastroenterology. 2003;125:372–379.PubMed Wildner-Christensen M, Moller Hansen J, Schaffalitzky De Schaffalitzky O. Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population. Gastroenterology. 2003;125:372–379.PubMed
4.
Zurück zum Zitat Johnson I. Galen: On Diseases and Symptoms. Cambridge: Cambridge University Press; 2006. Johnson I. Galen: On Diseases and Symptoms. Cambridge: Cambridge University Press; 2006.
5.
Zurück zum Zitat Whytt R. The Works of Robert Whytt. London: T. Becket and P.A. Dehondt & J. Balfour; 1767. Whytt R. The Works of Robert Whytt. London: T. Becket and P.A. Dehondt & J. Balfour; 1767.
6.
Zurück zum Zitat Johnson J. An Essay on Morbid Sensibility of the Stomach and Bowels. London: Thomas & George Underwood; 1827. Johnson J. An Essay on Morbid Sensibility of the Stomach and Bowels. London: Thomas & George Underwood; 1827.
7.
Zurück zum Zitat Meyer MJ, Goldschneider KR, Bielefeldt K, et al. Functional abdominal pain in adolescence: a biopsychosocial phenomenon. J Pain. 2008;9:984–990.PubMed Meyer MJ, Goldschneider KR, Bielefeldt K, et al. Functional abdominal pain in adolescence: a biopsychosocial phenomenon. J Pain. 2008;9:984–990.PubMed
8.
Zurück zum Zitat Clauwaert N, Jones MP, Holvoet L, et al. Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal? Neurogastroenterol Motil. 2012;24:1088–e565. Clauwaert N, Jones MP, Holvoet L, et al. Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal? Neurogastroenterol Motil. 2012;24:1088–e565.
9.
Zurück zum Zitat Janssen P, Scott Harris M, Jones M, et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol. 2013;108:1382–1391.PubMed Janssen P, Scott Harris M, Jones M, et al. The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol. 2013;108:1382–1391.PubMed
10.
Zurück zum Zitat Talley N, Shuter B, McCrudden G, et al. Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J Clin Gastroenterol. 1989;11:625–630.PubMed Talley N, Shuter B, McCrudden G, et al. Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia. J Clin Gastroenterol. 1989;11:625–630.PubMed
11.
Zurück zum Zitat Abrahams A. Dr. G. Herschell’s Textbook of Indigestion. 4th ed. New York: Longmans, Green and Company; 1920. Abrahams A. Dr. G. Herschell’s Textbook of Indigestion. 4th ed. New York: Longmans, Green and Company; 1920.
12.
Zurück zum Zitat Beaumont W. Experiments and Observations on the Gastric Juic and the Physiology of Digestion. Plattsburgh: FF Allen; 1833. Beaumont W. Experiments and Observations on the Gastric Juic and the Physiology of Digestion. Plattsburgh: FF Allen; 1833.
13.
Zurück zum Zitat Gill J. Indigestion: What It Is, What It Leads to. Philadelphia: Blackstone, Son & Co; 1883. Gill J. Indigestion: What It Is, What It Leads to. Philadelphia: Blackstone, Son & Co; 1883.
14.
Zurück zum Zitat Einhorn M. Diseases of the Stomach. New York: William Wood and Company; 1896. Einhorn M. Diseases of the Stomach. New York: William Wood and Company; 1896.
15.
Zurück zum Zitat Ewald C. Klink der Verdauungskrankheiten II. Die Krankheiten des Magens. 3rd ed. Berlin: Verlag von August Hirschwald; 1893. Ewald C. Klink der Verdauungskrankheiten II. Die Krankheiten des Magens. 3rd ed. Berlin: Verlag von August Hirschwald; 1893.
17.
Zurück zum Zitat Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMed Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMed
18.
Zurück zum Zitat Brunton T. On Disorders of Digestion. London: MacMillan and Co; 1893. Brunton T. On Disorders of Digestion. London: MacMillan and Co; 1893.
19.
Zurück zum Zitat Philip A. A Treatise on Indigestion and Its Consequences. London: Thomas and George Underwood; 1824. Philip A. A Treatise on Indigestion and Its Consequences. London: Thomas and George Underwood; 1824.
20.
Zurück zum Zitat Olafsdottir L, Gudjonsson H, Jonsdottir H, et al. Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria—a 10-year follow-up study. Aliment Pharmacol Ther. 2010;32:670–680.PubMed Olafsdottir L, Gudjonsson H, Jonsdottir H, et al. Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria—a 10-year follow-up study. Aliment Pharmacol Ther. 2010;32:670–680.PubMed
21.
Zurück zum Zitat Olafsdottir L, Gudjonsson H, Jonsdottir H, et al. Natural history of functional dyspepsia: a 10-year population-based study. Digestion. 2010;81:53–61.PubMed Olafsdottir L, Gudjonsson H, Jonsdottir H, et al. Natural history of functional dyspepsia: a 10-year population-based study. Digestion. 2010;81:53–61.PubMed
22.
Zurück zum Zitat Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al. Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies. Dig Liver Dis. 2012;44:211–217.PubMed Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al. Natural history of functional gastrointestinal disorders: comparison of two longitudinal population-based studies. Dig Liver Dis. 2012;44:211–217.PubMed
23.
Zurück zum Zitat Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528–533.PubMed Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528–533.PubMed
24.
Zurück zum Zitat Kindt S, Dubois D, Van Oudenhove L, et al. Relationship between symptom patterns, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil. 2009;21:1183–1188.PubMed Kindt S, Dubois D, Van Oudenhove L, et al. Relationship between symptom patterns, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil. 2009;21:1183–1188.PubMed
25.
Zurück zum Zitat Pfungen R. Ueber Atonie des Magens. Wien: Willhelm Braunmueller; 1887. Pfungen R. Ueber Atonie des Magens. Wien: Willhelm Braunmueller; 1887.
26.
Zurück zum Zitat Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2009;30:331–342.PubMed Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2009;30:331–342.PubMed
27.
Zurück zum Zitat Jones MP, Coppens E, Vos R, et al. A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach. Gut. 2013;62:1573–1580. Jones MP, Coppens E, Vos R, et al. A multidimensional model of psychobiological interactions in functional dyspepsia: a structural equation modelling approach. Gut. 2013;62:1573–1580.
28.
Zurück zum Zitat Osler W. The Principles and Practice of Medicine. New York: D. Appelton and Company; 1892. Osler W. The Principles and Practice of Medicine. New York: D. Appelton and Company; 1892.
29.
Zurück zum Zitat Friedenwald J. Functional diseases of the stomach. In: Osler WM, ed. Modern Medicine, vol. III. 2nd ed. Philadelphia: Lea & Febinger; 1914. Friedenwald J. Functional diseases of the stomach. In: Osler WM, ed. Modern Medicine, vol. III. 2nd ed. Philadelphia: Lea & Febinger; 1914.
31.
33.
Zurück zum Zitat Nyrén O, Lindberg G, Lindström E, et al. Economic costs of functional dyspepsia. Pharmacoeconomics. 1992;5:312–324. Nyrén O, Lindberg G, Lindström E, et al. Economic costs of functional dyspepsia. Pharmacoeconomics. 1992;5:312–324.
34.
Zurück zum Zitat Weir R, Backett E. Studies on the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut. 1968;9:75–83.PubMedCentralPubMed Weir R, Backett E. Studies on the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut. 1968;9:75–83.PubMedCentralPubMed
35.
Zurück zum Zitat Harvet G. The Vanities of Philosophy and Physic. London: W. Turner; 1700. Harvet G. The Vanities of Philosophy and Physic. London: W. Turner; 1700.
36.
Zurück zum Zitat Wightman C. A Treatise on the Sympathetic Relation Between the Stomach and the Brain. London: Simpkin, Marshall, and Co; 1840. Wightman C. A Treatise on the Sympathetic Relation Between the Stomach and the Brain. London: Simpkin, Marshall, and Co; 1840.
37.
Zurück zum Zitat Trousseau A, Pidoux H. Treatise on Therapeutics (translated by D.F. Lincoln). 9th ed. Vol II. London: Sampson Low, Marston, Searle, & Rivington; 1881. Trousseau A, Pidoux H. Treatise on Therapeutics (translated by D.F. Lincoln). 9th ed. Vol II. London: Sampson Low, Marston, Searle, & Rivington; 1881.
38.
Zurück zum Zitat Talley N, Weaver A, Zinsmeister A. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994;89:524–528.PubMed Talley N, Weaver A, Zinsmeister A. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994;89:524–528.PubMed
39.
Zurück zum Zitat Woodward M, Morrison CE, McColl KE. The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors. Aliment Pharmacol Ther. 1999;13:1505–1509.PubMed Woodward M, Morrison CE, McColl KE. The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors. Aliment Pharmacol Ther. 1999;13:1505–1509.PubMed
40.
Zurück zum Zitat Fenwick S. On atrophy of the Stomach and on the Nervous Affectations of the Digestive Organs. London: J. & A. Churchill; 1880. Fenwick S. On atrophy of the Stomach and on the Nervous Affectations of the Digestive Organs. London: J. & A. Churchill; 1880.
41.
Zurück zum Zitat Kussmaul A. Ueber die Behandlung der Magenerweiterung durch eine neue Methode mittles der Magenpumpe. Freiburg: H. Poppen und Sohn; 1869. Kussmaul A. Ueber die Behandlung der Magenerweiterung durch eine neue Methode mittles der Magenpumpe. Freiburg: H. Poppen und Sohn; 1869.
42.
Zurück zum Zitat Kahn M. Functional Diagnosis. New York: W.F. Prior Company Inc; 1920. Kahn M. Functional Diagnosis. New York: W.F. Prior Company Inc; 1920.
43.
Zurück zum Zitat Van Oudenhove L, Vandenberghe J, Geeraerts B, et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut. 2008;57:1666–1673.PubMed Van Oudenhove L, Vandenberghe J, Geeraerts B, et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut. 2008;57:1666–1673.PubMed
44.
Zurück zum Zitat Griffith G, Owen G, Kirkman S, et al. Measurement of rate of gastric emptying using chromium-51. Lancet. 1966;1:1244–1245. Griffith G, Owen G, Kirkman S, et al. Measurement of rate of gastric emptying using chromium-51. Lancet. 1966;1:1244–1245.
45.
Zurück zum Zitat Carman R. The Roentgen Diagnosis of Diseases of the Alimentary Canal. 2nd ed. Philadelphia London: W.B. Saunders Company; 1920. Carman R. The Roentgen Diagnosis of Diseases of the Alimentary Canal. 2nd ed. Philadelphia London: W.B. Saunders Company; 1920.
46.
Zurück zum Zitat Cowley D, Vernon P, Jones T, et al. Gastric emptying of solid meals after truncal vagotomy and pyloroplasty in human subjects. Gut. 1972;13:176–181.PubMedCentralPubMed Cowley D, Vernon P, Jones T, et al. Gastric emptying of solid meals after truncal vagotomy and pyloroplasty in human subjects. Gut. 1972;13:176–181.PubMedCentralPubMed
47.
48.
Zurück zum Zitat Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 1958;15:797–812. Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med. 1958;15:797–812.
49.
Zurück zum Zitat Wegener M, Börsch G, Schaffstein J, et al. Frequency of idiopathic gastric stasis and intestinal transit disorders in essential dyspepsia. J Clin Gastroenterol. 1989;11:163–168. Wegener M, Börsch G, Schaffstein J, et al. Frequency of idiopathic gastric stasis and intestinal transit disorders in essential dyspepsia. J Clin Gastroenterol. 1989;11:163–168.
50.
Zurück zum Zitat Stanghellini V, Tosetti C, Paternicò A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110:1036–1042.PubMed Stanghellini V, Tosetti C, Paternicò A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110:1036–1042.PubMed
51.
Zurück zum Zitat Waldron B, Cullen P, Kumar R, et al. Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study. Gut. 1991;32:246–251.PubMedCentralPubMed Waldron B, Cullen P, Kumar R, et al. Evidence for hypomotility in non-ulcer dyspepsia: a prospective multifactorial study. Gut. 1991;32:246–251.PubMedCentralPubMed
52.
Zurück zum Zitat Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.PubMedCentralPubMed Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.PubMedCentralPubMed
53.
Zurück zum Zitat Ejskjaer N, Dimcevski G, Wo J, et al. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2010;22:1069-e281.PubMed Ejskjaer N, Dimcevski G, Wo J, et al. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2010;22:1069-e281.PubMed
54.
Zurück zum Zitat Ejskjaer N, Wo JM, Esfandyari T, et al. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterol Motil. 2013;25:e140–e150. Ejskjaer N, Wo JM, Esfandyari T, et al. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterol Motil. 2013;25:e140–e150.
55.
Zurück zum Zitat McCallum RW, Cynshi O, TEAM UI. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther. 2007;26:107–116.PubMed McCallum RW, Cynshi O, TEAM UI. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment Pharmacol Ther. 2007;26:107–116.PubMed
56.
Zurück zum Zitat Shin A, Camilleri M, Busciglio I, et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013;11:1453.e4–1459.e4. Shin A, Camilleri M, Busciglio I, et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013;11:1453.e4–1459.e4.
57.
Zurück zum Zitat Yamagishi T, Debas HT. Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. Am J Physiol Endocrinol Metab. 1978;234:E375. Yamagishi T, Debas HT. Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus. Am J Physiol Endocrinol Metab. 1978;234:E375.
58.
Zurück zum Zitat Gleysteen J, Burdeshaw J, Hallenbeck G. Gastric emptying of liquids after different vagotomies and pyloroplasty. Surg Gynecol Obstet. 1976;142:41–48.PubMed Gleysteen J, Burdeshaw J, Hallenbeck G. Gastric emptying of liquids after different vagotomies and pyloroplasty. Surg Gynecol Obstet. 1976;142:41–48.PubMed
59.
Zurück zum Zitat Karamanolis G, Caenepeel P, Arts J, et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007;56:29–36.PubMedCentralPubMed Karamanolis G, Caenepeel P, Arts J, et al. Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? Gut. 2007;56:29–36.PubMedCentralPubMed
60.
Zurück zum Zitat Bennink RJ, van den Elzen BD, Kuiken SD, et al. Noninvasive measurement of gastric accommodation by means of pertechnetate SPECT: limiting radiation dose without losing image quality. J Nucl Med. 2004;45:147–152.PubMed Bennink RJ, van den Elzen BD, Kuiken SD, et al. Noninvasive measurement of gastric accommodation by means of pertechnetate SPECT: limiting radiation dose without losing image quality. J Nucl Med. 2004;45:147–152.PubMed
61.
62.
Zurück zum Zitat Fleisher D. Cyclic vomiting syndrome: a paroxismal disorder of brain-gut interaction. J Pediatr Gastroenterol Nutr. 1997;25:S13–S15.PubMed Fleisher D. Cyclic vomiting syndrome: a paroxismal disorder of brain-gut interaction. J Pediatr Gastroenterol Nutr. 1997;25:S13–S15.PubMed
63.
Zurück zum Zitat Aaron C. Diseases of the Digestive Organs. 3rd ed. Philadelphia: Lea & Febinger; 1921. Aaron C. Diseases of the Digestive Organs. 3rd ed. Philadelphia: Lea & Febinger; 1921.
64.
Zurück zum Zitat Mathieu A. Traité des maladies de l’éstomac et de lintestin. Paris: Octave Doin; 1901. Mathieu A. Traité des maladies de l’éstomac et de lintestin. Paris: Octave Doin; 1901.
65.
Zurück zum Zitat Bates S, Sjödén P, Fellenius J, et al. Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology. 1989;97:376–383.PubMed Bates S, Sjödén P, Fellenius J, et al. Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology. 1989;97:376–383.PubMed
66.
Zurück zum Zitat Nyrén O, Adami H-O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med. 1986;314:339–343.PubMed Nyrén O, Adami H-O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med. 1986;314:339–343.PubMed
67.
Zurück zum Zitat Talley NJ, Meineche S, Paré P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the bond and opera studies). Aliment Pharmacol Ther. 1998;12:1055–1065.PubMed Talley NJ, Meineche S, Paré P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the bond and opera studies). Aliment Pharmacol Ther. 1998;12:1055–1065.PubMed
68.
Zurück zum Zitat Meineche-Schmidt V, Christensen E. Which dyspepsia patients will benefit from omeprazole treatment [quest] Analysis of a Danish multicenter trial. Am J Gastroenterol. 2000;95:2777–2783.PubMed Meineche-Schmidt V, Christensen E. Which dyspepsia patients will benefit from omeprazole treatment [quest] Analysis of a Danish multicenter trial. Am J Gastroenterol. 2000;95:2777–2783.PubMed
69.
Zurück zum Zitat Dudekula A, O’Connell M, Bielefeldt K. Hospitalizations and testing in gastroparesis. J Gastroenterol Hepatol. 2011;26:1275–1282.PubMed Dudekula A, O’Connell M, Bielefeldt K. Hospitalizations and testing in gastroparesis. J Gastroenterol Hepatol. 2011;26:1275–1282.PubMed
70.
Zurück zum Zitat Parkman HP, Yates K, Hasler WL, et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol. 2011;9:1056–1064.PubMed Parkman HP, Yates K, Hasler WL, et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol. 2011;9:1056–1064.PubMed
71.
Zurück zum Zitat Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:187–194.PubMed Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:187–194.PubMed
72.
Zurück zum Zitat Moshiree B, Barboza J, Talley N. An update on current pharmacotherapy options for dyspepsia. Expert Opin Pharmacother. 2013;14:1737–1753.PubMed Moshiree B, Barboza J, Talley N. An update on current pharmacotherapy options for dyspepsia. Expert Opin Pharmacother. 2013;14:1737–1753.PubMed
73.
Zurück zum Zitat Arnott J. On Indigestion: Its Pathology and Treatment. London: John Churchill; 1848. Arnott J. On Indigestion: Its Pathology and Treatment. London: John Churchill; 1848.
74.
Zurück zum Zitat Hammer J, Führer M, Matiasek S. Hypersensitivity for capsaicin in patients with functional dyspepsia. Neurogastroenterol Motil. 2008;20:125–133.PubMed Hammer J, Führer M, Matiasek S. Hypersensitivity for capsaicin in patients with functional dyspepsia. Neurogastroenterol Motil. 2008;20:125–133.PubMed
75.
Zurück zum Zitat George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology. 1991;101:3–6.PubMed George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology. 1991;101:3–6.PubMed
76.
Zurück zum Zitat Vandenberghe J, Vos R, Persoons P, et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut. 2005;54:914–919.PubMedCentralPubMed Vandenberghe J, Vos R, Persoons P, et al. Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut. 2005;54:914–919.PubMedCentralPubMed
77.
Zurück zum Zitat Greydanus M, Vassallo M, Camilleri M, et al. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology. 1991;100:1311–1318.PubMed Greydanus M, Vassallo M, Camilleri M, et al. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology. 1991;100:1311–1318.PubMed
78.
Zurück zum Zitat Lémann M, Dederding J, Flourié B, et al. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci. 1991;36:1249–1254.PubMed Lémann M, Dederding J, Flourié B, et al. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci. 1991;36:1249–1254.PubMed
79.
Zurück zum Zitat Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140:1575–1585.PubMed Grover M, Farrugia G, Lurken MS, et al. Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology. 2011;140:1575–1585.PubMed
80.
Zurück zum Zitat Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101.e10–115.e10. Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101.e10–115.e10.
81.
Zurück zum Zitat Brown J. The Elements of Medicine: Elementa medicinae Brunonis. London: J.Johnson; 1787. Brown J. The Elements of Medicine: Elementa medicinae Brunonis. London: J.Johnson; 1787.
82.
Zurück zum Zitat Cannon W. Bodily Changes in Pain, Hunger, Fear and Rage. New York: D. Appelton and Company; 1916. Cannon W. Bodily Changes in Pain, Hunger, Fear and Rage. New York: D. Appelton and Company; 1916.
83.
Zurück zum Zitat Talley N, Fung L, Gilligan I, et al. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology. 1986;90:886–892.PubMed Talley N, Fung L, Gilligan I, et al. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology. 1986;90:886–892.PubMed
84.
Zurück zum Zitat Haug T, Svebak S, Wilhelmsen I, et al. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res. 1994;38:281–291.PubMed Haug T, Svebak S, Wilhelmsen I, et al. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res. 1994;38:281–291.PubMed
85.
Zurück zum Zitat Bennett E, Beaurepaire J, Langeluddecke P, et al. Life stress and non-ulcer dyspepsia: a case-control study. J Psychosom Res. 1991;35:579–590.PubMed Bennett E, Beaurepaire J, Langeluddecke P, et al. Life stress and non-ulcer dyspepsia: a case-control study. J Psychosom Res. 1991;35:579–590.PubMed
86.
Zurück zum Zitat Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut. 1996;38:822–855.PubMedCentralPubMed Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut. 1996;38:822–855.PubMedCentralPubMed
87.
Zurück zum Zitat Van Oudenhove L, Vandenberghe J, Vos R, et al. Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia. Psychosom Med. 2011;73:648–655.PubMed Van Oudenhove L, Vandenberghe J, Vos R, et al. Abuse history, depression, and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia. Psychosom Med. 2011;73:648–655.PubMed
88.
Zurück zum Zitat Menniger W. Functional disorders of the gastro-intestinal tract: the “gastro-intestinal neuroses”. Am J Dig Dis Nutrit. 1937;4:447. Menniger W. Functional disorders of the gastro-intestinal tract: the “gastro-intestinal neuroses”. Am J Dig Dis Nutrit. 1937;4:447.
89.
Zurück zum Zitat Bennell J, Taylor C. A loss of social eating: the experience of individuals living with gastroparesis. J Clin Nurs. 2013;22:2812–2821. Bennell J, Taylor C. A loss of social eating: the experience of individuals living with gastroparesis. J Clin Nurs. 2013;22:2812–2821.
90.
Zurück zum Zitat Talley NJ, Locke GR III, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006;55:933–939.PubMedCentralPubMed Talley NJ, Locke GR III, Lahr BD, et al. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006;55:933–939.PubMedCentralPubMed
91.
Zurück zum Zitat Aro P, Talley NJ, Agréus L, et al. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33:1215–1224.PubMed Aro P, Talley NJ, Agréus L, et al. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33:1215–1224.PubMed
92.
Zurück zum Zitat Jaffe JK, Paladugu S, Gaughan JP, et al. Characteristics of nausea and its effects on quality of life in diabetic and idiopathic gastroparesis. J Clin Gastroenterol. 2011;45:317–321.PubMed Jaffe JK, Paladugu S, Gaughan JP, et al. Characteristics of nausea and its effects on quality of life in diabetic and idiopathic gastroparesis. J Clin Gastroenterol. 2011;45:317–321.PubMed
93.
94.
Zurück zum Zitat Williams A, Edwards F, Lewis T, et al. Investigation of non-ulcer dyspepsia by gastric biopsy. BMJ. 1957;1:372–377.PubMedCentralPubMed Williams A, Edwards F, Lewis T, et al. Investigation of non-ulcer dyspepsia by gastric biopsy. BMJ. 1957;1:372–377.PubMedCentralPubMed
95.
Zurück zum Zitat Beck I, Kahn D, Lacerte M, et al. “Chronic duodenitis’: a clinical pathological entity? Gut. 1965;6:376–383.PubMedCentralPubMed Beck I, Kahn D, Lacerte M, et al. “Chronic duodenitis’: a clinical pathological entity? Gut. 1965;6:376–383.PubMedCentralPubMed
97.
Zurück zum Zitat Barnes R, Gear M, Nicol A, et al. Study of dyspepsia in a general practice as assessed by endoscopy and radiology. Br Med J. 1974;4:214–216.PubMedCentralPubMed Barnes R, Gear M, Nicol A, et al. Study of dyspepsia in a general practice as assessed by endoscopy and radiology. Br Med J. 1974;4:214–216.PubMedCentralPubMed
99.
Zurück zum Zitat Loffeld R, Potters H, Stobberingh E, et al. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut. 1989;30:1206–1212.PubMedCentralPubMed Loffeld R, Potters H, Stobberingh E, et al. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut. 1989;30:1206–1212.PubMedCentralPubMed
100.
Zurück zum Zitat Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992;304:1276–1279.PubMedCentralPubMed Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992;304:1276–1279.PubMedCentralPubMed
101.
Zurück zum Zitat Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562–1566.PubMed Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562–1566.PubMed
102.
Zurück zum Zitat Patchett S, Beattie S, Leen E, et al. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ. 1991;303:1238–1240.PubMedCentralPubMed Patchett S, Beattie S, Leen E, et al. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ. 1991;303:1238–1240.PubMedCentralPubMed
103.
Zurück zum Zitat Talley NJ, Vakil N, Ballard ED, et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999;341:1106–1111.PubMed Talley NJ, Vakil N, Ballard ED, et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med. 1999;341:1106–1111.PubMed
104.
Zurück zum Zitat Greenberg PD, Cello JP. Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia. Arch Intern Med. 1999;159:2283–2288.PubMed Greenberg PD, Cello JP. Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia. Arch Intern Med. 1999;159:2283–2288.PubMed
105.
Zurück zum Zitat Mazzoleni LE, Sander GB, Francesconi CFdM, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med. 2011;171:1929–1936.PubMed Mazzoleni LE, Sander GB, Francesconi CFdM, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med. 2011;171:1929–1936.PubMed
106.
Zurück zum Zitat Moayyedi P, Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet. 2000;355:1665–1669.PubMed Moayyedi P, Feltbower R, Brown J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet. 2000;355:1665–1669.PubMed
107.
Zurück zum Zitat Faussone-Pellegrini M, Grover M, Pasricha P, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis: the NIDDK gastroparesis clinical research consortium (GpCRC). J Cell Mol Med. 2012;16:1573–1581. Faussone-Pellegrini M, Grover M, Pasricha P, et al. Ultrastructural differences between diabetic and idiopathic gastroparesis: the NIDDK gastroparesis clinical research consortium (GpCRC). J Cell Mol Med. 2012;16:1573–1581.
108.
Zurück zum Zitat Olausson EA, Storsrud S, Grundin H, et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014;109:375–385. Olausson EA, Storsrud S, Grundin H, et al. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014;109:375–385.
109.
Zurück zum Zitat Scott E, Zweighaft J. Blood sugar in man following the rectal administration of dextrose. Arch Intern Med (Chic). 1932;49:221–226. Scott E, Zweighaft J. Blood sugar in man following the rectal administration of dextrose. Arch Intern Med (Chic). 1932;49:221–226.
110.
Zurück zum Zitat Jacober S, Narayan A, Strodel W, et al. Jejunostomy feeding in the management of gastroparesis diabeticorum. Diabetes Care. 1986;9:217–219.PubMed Jacober S, Narayan A, Strodel W, et al. Jejunostomy feeding in the management of gastroparesis diabeticorum. Diabetes Care. 1986;9:217–219.PubMed
111.
Zurück zum Zitat Ford A, Moayyedi P. Dyspepsia. Curr Opin Gastroenterol. 2013;29:662–668.PubMed Ford A, Moayyedi P. Dyspepsia. Curr Opin Gastroenterol. 2013;29:662–668.PubMed
113.
Zurück zum Zitat Aktas A, Caner B, Ozturk F, et al. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Ann Nucl Med. 1999;13:231–234.PubMed Aktas A, Caner B, Ozturk F, et al. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Ann Nucl Med. 1999;13:231–234.PubMed
114.
Zurück zum Zitat Lunding J, Gilja O, Hausken T, et al. Distension-induced gastric accommodation in functional dyspepsia: effect of autonomic manipulation. Neurogastroenterol Motil. 2007;19:365–375.PubMed Lunding J, Gilja O, Hausken T, et al. Distension-induced gastric accommodation in functional dyspepsia: effect of autonomic manipulation. Neurogastroenterol Motil. 2007;19:365–375.PubMed
115.
Zurück zum Zitat Machella T, Hodges H, Lorber S. The restoration of gastric motility by urethane or B-methyl choline after section of the vagus nerves for peptic ulcer. Gastroenterology. 1947;8:36–51.PubMed Machella T, Hodges H, Lorber S. The restoration of gastric motility by urethane or B-methyl choline after section of the vagus nerves for peptic ulcer. Gastroenterology. 1947;8:36–51.PubMed
116.
117.
Zurück zum Zitat Malagelada J, Rees W, Mazzotta L, et al. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology. 1980;78:286–893.PubMed Malagelada J, Rees W, Mazzotta L, et al. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology. 1980;78:286–893.PubMed
118.
Zurück zum Zitat McCallum R, Ricci D, Rakatansky H, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983;6:463–467.PubMed McCallum R, Ricci D, Rakatansky H, et al. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983;6:463–467.PubMed
119.
Zurück zum Zitat Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322:1028–1031.PubMed Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322:1028–1031.PubMed
120.
Zurück zum Zitat McCallum RW, Lembo A, Esfandyari T, et al. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterol Motil. 2013;25:e705–e717. McCallum RW, Lembo A, Esfandyari T, et al. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterol Motil. 2013;25:e705–e717.
121.
Zurück zum Zitat Corinaldesi R, Stanghellini V, Raiti C, et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut. 1987;28:300–305.PubMedCentralPubMed Corinaldesi R, Stanghellini V, Raiti C, et al. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut. 1987;28:300–305.PubMedCentralPubMed
122.
Zurück zum Zitat Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001;49:395–401.PubMedCentralPubMed Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001;49:395–401.PubMedCentralPubMed
123.
Zurück zum Zitat Storr M, Sibaev A, Weiser D, et al. Herbal extracts modulate the amplitude and frequency of slow waves in circular smooth muscle of mouse small intestine. Digestion. 2004;70:257–264.PubMed Storr M, Sibaev A, Weiser D, et al. Herbal extracts modulate the amplitude and frequency of slow waves in circular smooth muscle of mouse small intestine. Digestion. 2004;70:257–264.PubMed
124.
Zurück zum Zitat Pilichiewicz AN, Horowitz M, Russo A, et al. Effects of iberogast[reg] on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol. 2007;102:1276–1283.PubMed Pilichiewicz AN, Horowitz M, Russo A, et al. Effects of iberogast[reg] on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol. 2007;102:1276–1283.PubMed
125.
Zurück zum Zitat Braden B, Caspary W, Börner N, et al. Clinical effects of STW 5 (Iberogast®) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil. 2009;21:632-e25. Braden B, Caspary W, Börner N, et al. Clinical effects of STW 5 (Iberogast®) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil. 2009;21:632-e25.
127.
Zurück zum Zitat Talley N, McNeil D, Hayden A, et al. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology. 1986;91:149–156.PubMed Talley N, McNeil D, Hayden A, et al. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. Gastroenterology. 1986;91:149–156.PubMed
128.
Zurück zum Zitat Müller P, Hotz J, Franz E, et al. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany. Arzneimittelforschung. 1994;44:1130–1132.PubMed Müller P, Hotz J, Franz E, et al. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany. Arzneimittelforschung. 1994;44:1130–1132.PubMed
129.
Zurück zum Zitat Peura D, Kovacs T, Metz D, et al. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med. 2004;116:740–748.PubMed Peura D, Kovacs T, Metz D, et al. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med. 2004;116:740–748.PubMed
130.
Zurück zum Zitat van Zanten S, Armstrong D, Chiba N, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled “ENTER” trial. Am J Gastroenterol. 2006;101:2096–2106.PubMed van Zanten S, Armstrong D, Chiba N, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled “ENTER” trial. Am J Gastroenterol. 2006;101:2096–2106.PubMed
131.
Zurück zum Zitat Nussbaum H. A new psychotherapeutic-anticholinergic combination for gastrointestinal disorders. Am J Gastroenterol. 1962;38:575–582.PubMed Nussbaum H. A new psychotherapeutic-anticholinergic combination for gastrointestinal disorders. Am J Gastroenterol. 1962;38:575–582.PubMed
132.
Zurück zum Zitat Marks L. Clinical and x-ray evaluation of donnatal and donnatal extentabs in functional disturbances of the gastrointestinal tract. Am J Gastroenterol. 1957;27:180–189.PubMed Marks L. Clinical and x-ray evaluation of donnatal and donnatal extentabs in functional disturbances of the gastrointestinal tract. Am J Gastroenterol. 1957;27:180–189.PubMed
133.
Zurück zum Zitat Parkman HP, Van Natta ML, Abell TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the norig randomized clinical trial. JAMA. 2013;310:2640–2649.PubMed Parkman HP, Van Natta ML, Abell TL, et al. Effect of nortriptyline on symptoms of idiopathic gastroparesis: the norig randomized clinical trial. JAMA. 2013;310:2640–2649.PubMed
134.
Zurück zum Zitat van Kerkhoven LAS, Laheij RJF, Aparicio N, et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind. Placebo-controlled trial. Clin Gastroenterol Hepatol. 2008;6:746–752.PubMed van Kerkhoven LAS, Laheij RJF, Aparicio N, et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind. Placebo-controlled trial. Clin Gastroenterol Hepatol. 2008;6:746–752.PubMed
136.
Zurück zum Zitat Read NW, Abitbol JL, Bardhan KD, et al. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut. 1997;41:664–668.PubMedCentralPubMed Read NW, Abitbol JL, Bardhan KD, et al. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut. 1997;41:664–668.PubMedCentralPubMed
137.
Zurück zum Zitat Jones KL, Wishart JM, Berry MK, et al. Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol Ther. 2000;14:937–943.PubMed Jones KL, Wishart JM, Berry MK, et al. Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol Ther. 2000;14:937–943.PubMed
138.
Zurück zum Zitat Ryan J, Heckler C, Roscoe J, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012;20:1479–1489.PubMedCentralPubMed Ryan J, Heckler C, Roscoe J, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012;20:1479–1489.PubMedCentralPubMed
139.
Zurück zum Zitat Hasler WL, Parkman HP, Wilson LA, et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol. 2010;105:2357–2367.PubMedCentralPubMed Hasler WL, Parkman HP, Wilson LA, et al. Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis. Am J Gastroenterol. 2010;105:2357–2367.PubMedCentralPubMed
140.
Zurück zum Zitat Soo S, Forman D, Delaney BC, et al. A systematic review of psychological therapies for nonulcer dyspepsia. Am J Gastroenterol. 2004;99:1817–1822.PubMed Soo S, Forman D, Delaney BC, et al. A systematic review of psychological therapies for nonulcer dyspepsia. Am J Gastroenterol. 2004;99:1817–1822.PubMed
141.
Zurück zum Zitat Stockton C. Clinical results of gastric faradizations. Am J Med Sci. 1880;100:20–25. Stockton C. Clinical results of gastric faradizations. Am J Med Sci. 1880;100:20–25.
142.
Zurück zum Zitat McCallum RW, De Z, Chen J, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology. 1998;114:456–461.PubMed McCallum RW, De Z, Chen J, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology. 1998;114:456–461.PubMed
143.
Zurück zum Zitat Bielefeldt K. Factors influencing admission and outcomes in gastroparesis. Neurogastroenterol Motil. 2013;25:389-e294. Bielefeldt K. Factors influencing admission and outcomes in gastroparesis. Neurogastroenterol Motil. 2013;25:389-e294.
144.
Zurück zum Zitat Jung H-K, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.PubMedCentralPubMed Jung H-K, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.PubMedCentralPubMed
Metadaten
Titel
From Ischochymia to Gastroparesis: Proposed Mechanisms and Preferred Management of Dyspepsia Over the Centuries
verfasst von
Klaus Bielefeldt
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3144-0

Weitere Artikel der Ausgabe 6/2014

Digestive Diseases and Sciences 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.